Tenaya Therapeutics Inc. Common Stock (TNYA)
Stock · NASDAQ · Health Care
$0.691as of 8/28/2026
Price chart
Open in TradingViewActive signals
About TNYA
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, wh…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 70
- Website
- www.tenayatherapeutics.com/
Fundamentals
- 1-day range
- $0.6869$0.7036
- Market cap
- $157.50M
- P/E (trailing)
- —
- P/E (forward)
- -1.76
- EPS (trailing)
- $-0.53
- Dividend yield
- —
- Beta
- 2.93
- Avg. volume
- 2.46M
Forecasts
5 analyst ratings
Tenaya Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- TNYATenaya Therapeutics Inc. Common Stock$0.691▼ 0.58%Market cap $157.50MP/E —$0.532$2.35
- HUMAHumacyte Inc. Common Stock$0.6538▼ 5.66%Market cap $157.54MP/E —$0.5261$2.55
- CRDLCardiol Therapeutics Inc. Class A Common Shares$1.94▼ 6.07%Market cap $156.77MP/E —$0.88$1.82
- CRBUCaribou Biosciences Inc. Common Stock$1.62▼ 2.41%Market cap $162.66MP/E —$1.38$3.54
- MOLNMolecular Partners AG American Depositary Shares$4.5▼ 3.27%Market cap $163.47MP/E —$2.66$3.96
- LENZLENZ Therapeutics Inc. Common Stock$5.12▲ 6.34%Market cap $163.67MP/E —$4.54$50.4
- ARMPArmata Pharmaceuticals Inc. Common Stock$5.24▼ 3.50%Market cap $172.54MP/E —$2.4$16.34
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| TNYA Tenaya Therapeutics Inc. Common Stock | $157.50M | — | $0.691 | ▼ 0.58% | $0.532$2.35 |
| HUMA Humacyte Inc. Common Stock | $157.54M | — | $0.6538 | ▼ 5.66% | $0.5261$2.55 |
| CRDL Cardiol Therapeutics Inc. Class A Common Shares | $156.77M | — | $1.94 | ▼ 6.07% | $0.88$1.82 |
| CRBU Caribou Biosciences Inc. Common Stock | $162.66M | — | $1.62 | ▼ 2.41% | $1.38$3.54 |
| MOLN Molecular Partners AG American Depositary Shares | $163.47M | — | $4.5 | ▼ 3.27% | $2.66$3.96 |
| LENZ LENZ Therapeutics Inc. Common Stock | $163.67M | — | $5.12 | ▲ 6.34% | $4.54$50.4 |
| ARMP Armata Pharmaceuticals Inc. Common Stock | $172.54M | — | $5.24 | ▼ 3.50% | $2.4$16.34 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Tenaya Therapeutics, Inc. (TNYA) Presents at Canaccord Genuity's 46th Annual Growth Conference TranscriptSeekingAlpha · 8/14/2026
- Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business UpdateYahoo · 8/5/2026
- Tenaya Therapeutics Q2 EPS $(0.20) Misses $(0.05) Estimate, Sales $1.110M Miss $10.000M EstimateBenzinga · 8/5/2026
- Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth ConferenceYahoo · 8/4/2026
Insider Activity
Insider Actions →- Eric J. Hyllengren · July 13, 2026 · Grant1.65M
- Srivastava Deepak · May 28, 2026 · Grant120.0K
- Burroughs Amy L. · May 28, 2026 · Grant120.0K
- Stehman-Breen Catherine · May 28, 2026 · Grant120.0K
- June Lee · May 28, 2026 · Grant120.0K
- Karah Herdman Parschauer · May 28, 2026 · Grant120.0K
- Walsh Jeffrey T. · May 28, 2026 · Grant120.0K
- Williams R Sanders · May 28, 2026 · Grant120.0K
- Whittemore Tingley · May 18, 2026 · Sale3.1K @ $0.7936
- Tomohiro Higa · May 18, 2026 · Sale1.5K @ $0.7932
- Faraz Ali · May 18, 2026 · Sale3.4K @ $0.7934
Institutional Ownership
March 31, 2026
- Total shares held
- 53.57M
- Total value held
- $36.12M
- Institutional holders
- 100
- Unknown8.48M
- Unknown5.46M
- Unknown4.38M
- Unknown4.29M
- Unknown3.71M
- Unknown3.70M
- Unknown2.71M
- Unknown2.00M
- Unknown2.00M
- Unknown1.56M
See the full, filterable feed with live charts on the MarketWall dashboard.